TROSPIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trospium, and when can generic versions of Trospium launch?
Trospium is a drug marketed by Actavis Labs Fl Inc, Granules, Padagis Us, Upsher Smith Labs, Utopic Pharms, Apotex, Glenmark Pharms Ltd, Heritage Pharms Inc, Invagen Pharms, Macleods Pharms Ltd, and Zameer Pharms. and is included in twelve NDAs.
The generic ingredient in TROSPIUM is trospium chloride. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trospium
A generic version of TROSPIUM was approved as trospium chloride by GLENMARK PHARMS LTD on August 13th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TROSPIUM?
- What are the global sales for TROSPIUM?
- What is Average Wholesale Price for TROSPIUM?
Summary for TROSPIUM
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for TROSPIUM |
| DailyMed Link: | TROSPIUM at DailyMed |
US Patents and Regulatory Information for TROSPIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 091289-001 | Oct 12, 2012 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 091575-001 | Aug 13, 2010 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Upsher Smith Labs | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 091635-001 | Apr 29, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zameer Pharms | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 215781-001 | Feb 16, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Heritage Pharms Inc | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 204945-001 | Aug 30, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Granules | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 213185-001 | Apr 23, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
